Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 69
Filtrar
1.
J Nanobiotechnology ; 19(1): 304, 2021 Oct 02.
Artículo en Inglés | MEDLINE | ID: mdl-34600530

RESUMEN

BACKGROUND: Although the treatments of skin wounds have greatly improved with the increase in therapeutic methods and agents, available interventions still cannot meet the current clinical needs. Therefore, the development of new pro-regenerative therapies remains urgent. Owing to their unique characteristics, both nanomaterials and peptides have provided novel clues for the development of pro-regenerative agents, however, more efforts were still be awaited and anticipated. RESULTS: In the current research, Hollow polydopamine (HPDA) nanoparticles were synthesized and HPDA nanoparticles loading with RL-QN15 (HPDAlR) that was an amphibian-derived peptide with obvious prohealing activities were prepared successfully. The characterization, biodistribution and clearance of both HPDA nanoparticles and HPDAlR were evaluated, the loading efficiency of HPDA against RL-QN15 and the slow-releasing rate of RL-QN15 from HPDAlR were also determined. Our results showed that both HPDA nanoparticles and HPDAlR exerted no obvious toxicity against keratinocyte, macrophage and mice, and HPDA nanoparticles showed no prohealing potency in vivo and in vitro. Interestingly, HPDAlR significantly enhanced the ability of RL-QN15 to accelerate the healing of scratch of keratinocytes and selectively modulate the release of healing-involved cytokines from macrophages. More importantly, in comparison with RL-QN15, by evaluating on animal models of full-thickness injured skin wounds in mice and oral ulcers in rats, HPDAlR showed significant increasing in the pro-regenerative potency of 50 and 10 times, respectively. Moreover, HPDAlR also enhanced the prohealing efficiency of peptide RL-QN15 against skin scald in mice and full-thickness injured wounds in swine. CONCLUSIONS: HPDA obviously enhanced the pro-regenerative potency of RL-QN15 in vitro and in vivo, hence HPDAlR exhibited great potential in the development of therapeutics for skin wound healing.


Asunto(s)
Fármacos Dermatológicos , Indoles , Nanopartículas , Péptidos , Polímeros , Cicatrización de Heridas/efectos de los fármacos , Animales , Supervivencia Celular/efectos de los fármacos , Fármacos Dermatológicos/química , Fármacos Dermatológicos/farmacología , Fármacos Dermatológicos/toxicidad , Modelos Animales de Enfermedad , Células HaCaT , Humanos , Indoles/química , Indoles/toxicidad , Masculino , Ratones , Ratones Desnudos , Nanopartículas/química , Nanopartículas/toxicidad , Péptidos/química , Péptidos/farmacología , Péptidos/toxicidad , Polímeros/química , Polímeros/toxicidad , Células RAW 264.7 , Ratas Sprague-Dawley , Piel/efectos de los fármacos , Piel/lesiones , Porcinos
2.
Toxicology ; 458: 152840, 2021 06 30.
Artículo en Inglés | MEDLINE | ID: mdl-34175381

RESUMEN

Methotrexate (MTX) is one of the most effective and widely used drugs in the management of autoimmune and dermatological diseases. Rheumatoid arthritis and psoriasis patients who are under long term MTX-therapy are at high risk of developing a liver injury. Accumulation of intracellular MTX-polyglutamate (MTX-PG), a metabolite of MTX triggers oxidative stress, inflammation, steatosis, fibrosis, and apoptosis in hepatocytes. MTX-PG causes oxidative stress in the liver by inducing lipid peroxidation thereby releasing reactive oxygen species and suppressing antioxidant response elements. MTX-PG induces several pro-inflammatory signaling pathways and cytokines such as tumor necrosis factor-α, nuclear factor kappa B and interleukin 6 (IL-6), IL- ß1, IL-12. MTX-PG depletes hepatic folate level and decreases RNA and DNA synthesis leading to hepatocyte death. MTX-PG inhibits 5-aminoimidazole-4-carboxamide ribonucleotide transformylase enzyme and thereby causes accumulation of intracellular adenosine, which causes activation of hepatic stellate cells, extracellular matrix accumulation and hepatic fibrosis. MTX-PG induces hepatocytes apoptosis by activation of caspase 3 via the intrinsic pathway. Clinically, aggravation of underlying fatty liver to non-alcoholic steatohepatitis with fibrosis seems to be an important mechanism of liver injury in MTX-treated RA patients. Therefore, there is a need for monitoring liver injury in RA, psoriatic and cancer patients with NAFLD and fibrosis risk factors during MTX treatment. This review summarizes the possible molecular mechanism of MTX-induced hepatotoxicity. It may pave the way for early detection of liver injury and develop novel strategies for treating MTX mediated hepatotoxicity.


Asunto(s)
Antirreumáticos/toxicidad , Enfermedad Hepática Inducida por Sustancias y Drogas/patología , Enfermedad Hepática Inducida por Sustancias y Drogas/terapia , Fármacos Dermatológicos/toxicidad , Metotrexato/toxicidad , Antirreumáticos/efectos adversos , Antirreumáticos/uso terapéutico , Artritis Reumatoide/complicaciones , Artritis Reumatoide/tratamiento farmacológico , Fármacos Dermatológicos/efectos adversos , Fármacos Dermatológicos/uso terapéutico , Humanos , Metotrexato/efectos adversos , Metotrexato/uso terapéutico , Psoriasis/complicaciones , Psoriasis/tratamiento farmacológico
3.
Anat Rec (Hoboken) ; 303(6): 1642-1652, 2020 06.
Artículo en Inglés | MEDLINE | ID: mdl-32421930

RESUMEN

Laminin-332 is a basement membrane protein composed of three genetically distinct polypeptide chains that actively promote both skin epidermal cell adhesion and migration. Proteolytic fragments of the laminin γ2 chain stimulate migration and scattering of keratinocytes and cancer cells. Sulfur mustard (SM) is a bifunctional alkylating agent that induces separation of basal keratinocytes from the dermal-epidermal junction and invokes a strong inflammatory response leading to delayed wound repair. In the present studies, the role of laminin γ2 in SM-induced skin injury and wound repair was investigated using the mouse ear vesicant model. We found that laminin γ2 chain mRNA was preferentially upregulated in mouse ear skin exposed to SM. In situ hybridization confirmed overexpression of laminin γ2 transcript. Western blot analysis showed increased protein expression of the full-length proform of laminin γ2 and smaller processed fragments of laminin γ2 in skin exposed to SM. Dual immunofluorescence labeling indicated that laminin γ2 fragments are prevalent in suprabasal keratinocytes behind the leading edge in areas of hyperplasia in injured skin. In addition, co-expression of laminin γ2 and the senescent marker, p16-INK4a was found to overlap with the hyperplastic migratory epithelial sheet. This observation is similar to hypermotile keratinocytes reported in invasive carcinoma cells. Overall, our studies indicate that laminin γ2 is preferentially expressed in skin post SM exposure and that protein expression appears to become progressively more fragmented. The laminin γ2 fragments may play a role in regulating SM-induced skin wound repair. Anat Rec, 2020. © 2020 American Association for Anatomy.


Asunto(s)
Fármacos Dermatológicos/toxicidad , Laminina/metabolismo , Gas Mostaza/toxicidad , Piel/metabolismo , Cicatrización de Heridas/fisiología , Animales , Movimiento Celular/fisiología , Queratinocitos/efectos de los fármacos , Queratinocitos/metabolismo , Laminina/genética , Ratones , Piel/efectos de los fármacos , Regulación hacia Arriba
4.
Am J Emerg Med ; 36(9): 1719.e3-1719.e4, 2018 09.
Artículo en Inglés | MEDLINE | ID: mdl-29861373

RESUMEN

We present the case of a woman in her 50s with past medical history significant for psoriasis treated with methotrexate on a stable dose for the past 20 years, diabetes mellitus and chronic kidney disease. In the setting of a long flight, dehydration and non steroidal anti-inflammatory drug consumption, the patient presented to the emergency department with oral mucositis and cutaneous erosions and ulcers of the psoriasis plaques. MTX levels were normal corroborated by three different measurements in 24 h. Initially the complete blood count tests were significant for macrocytic, thrombocytopenia (82.000 103/L) and impaired kidney function. The patient was diagnosed of acute methotrexate toxicity and started on intravenous folinic acid. In 24 h the patient developed severe pancytopenia. She required treatment with colony-stimulating factors, platelet and blood transfusions. After 10 days, the CBC improved to normal levels and the cutaneous lesions resolved.


Asunto(s)
Fármacos Dermatológicos/toxicidad , Metotrexato/toxicidad , Fármacos Dermatológicos/uso terapéutico , Femenino , Humanos , Metotrexato/uso terapéutico , Persona de Mediana Edad , Psoriasis/tratamiento farmacológico , Úlcera Cutánea/inducido químicamente , Estomatitis/inducido químicamente
5.
Eur J Pharm Sci ; 120: 142-151, 2018 Jul 30.
Artículo en Inglés | MEDLINE | ID: mdl-29684425

RESUMEN

The aim of present study was to design and optimize 0.1% adapalene loaded nano-emulsion to improve the drug efficacy and increase its user compliance. Effect of type and concentration of surfactants was studied on size of 0.1% adapalene loaded nano-emulsion. Optimized formulation was then evaluated for particle size, polydispersity index, morphology, viscosity, and pH. Subsequently, 1% carbopol® 934 was incorporated to the optimized formulation for preparation of its gel form. The efficacy and safety of 0.1% adapalene loaded nano-emulsion gel was assessed compared to marketed gel containing 0.1% adapalene. In-vitro studies showed that adapalene permeation through the skin was negligible in both adapalene loaded nano-emulsion gel and adapalene marketed gel. Furthermore, drug distribution studies in skin indicated higher retention of adapalene in the dermis in adapalene loaded nano-emulsion gel compared with adapalene marketed gel. Antibacterial activity against Propionibacterium acnes showed that adapalene loaded nano-emulsion is effective in reducing minimum inhibitory concentration of the formulation in comparison with tea tree oil nano-emulsion, and pure tea tree oil. In vivo skin irritation studies showed absence of irritancy for adapalene loaded nano-emulsion gel. Also, blood and liver absorption of the drug, histological analysis of liver and liver enzyme activity of rats after 90 days' treatment were investigated. No drug was detected in blood/liver which in addition to an absence of any adverse effect on liver and enzymes showed the potential of adapalene loaded nano-emulsion gel as a novel carrier for topical delivery of adapalene.


Asunto(s)
Adapaleno/administración & dosificación , Antiinfecciosos Locales/administración & dosificación , Fármacos Dermatológicos/administración & dosificación , Nanoestructuras , Propionibacterium acnes/efectos de los fármacos , Absorción Cutánea , Piel/metabolismo , Aceite de Árbol de Té/administración & dosificación , Adapaleno/química , Adapaleno/metabolismo , Adapaleno/toxicidad , Administración Cutánea , Animales , Antiinfecciosos Locales/química , Antiinfecciosos Locales/metabolismo , Antiinfecciosos Locales/toxicidad , Fármacos Dermatológicos/química , Fármacos Dermatológicos/metabolismo , Fármacos Dermatológicos/toxicidad , Combinación de Medicamentos , Composición de Medicamentos , Emulsiones , Geles , Concentración de Iones de Hidrógeno , Nanotecnología , Tamaño de la Partícula , Permeabilidad , Propionibacterium acnes/crecimiento & desarrollo , Conejos , Tensoactivos/química , Aceite de Árbol de Té/química , Aceite de Árbol de Té/metabolismo , Aceite de Árbol de Té/toxicidad , Tecnología Farmacéutica/métodos , Viscosidad
6.
Eur Ann Allergy Clin Immunol ; 50(6): 273-276, 2018 11.
Artículo en Inglés | MEDLINE | ID: mdl-29384118

RESUMEN

Summary: DRESS (drug reaction with eosinophilia and systemic symptoms) is a rare but potentially life-threatening disorder characterized by fever, skin eruption, haematological abnormalities and multi-organ dysfunction after drug exposure. The pathophysiology is thought to be related to interactions between culprit drugs, viral reactivation and T-lymphocytes activation. We report 4 paediatric patients with DRESS who were treated at our centre over the past 12 years. Most cases improved after corticosteroids. Other immunosuppressive medications were attempted in refractory cases with varied outcomes. Patient 3 was the first reported case that involved the use of infliximab, a TNF-α inhibitor, for DRESS. Although clinical efficacy was not observed for this one patient, a previous study demonstrated that patients with DRESS, disease progression and HHV-6 reactivation had elevated pre-treatment TNF- α and IL-6 levels. Further research is needed to explore the role of these cytokines in DRESS.


Asunto(s)
Fármacos Dermatológicos/toxicidad , Síndrome de Hipersensibilidad a Medicamentos/tratamiento farmacológico , Síndrome de Hipersensibilidad a Medicamentos/epidemiología , Eosinofilia/inducido químicamente , Infliximab/toxicidad , Adolescente , Corticoesteroides/uso terapéutico , Preescolar , Síndrome de Hipersensibilidad a Medicamentos/diagnóstico , Femenino , Hong Kong/epidemiología , Humanos , Masculino , Pruebas Cutáneas , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores
7.
Toxicol In Vitro ; 45(Pt 3): 397-408, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-28389280

RESUMEN

In the context of developing a new natural product-based cosmetic, the in vitro efficacy and safety evaluations of a complex botanical mixture based on Eugenia dysenterica leaf hydroalcoholic extract (EDE) (2.5-1000µg/mL) were carried out. Chromatographic analysis demonstrated the presence of the tannin (ellagic acid) and flavonoids (quercetin and gallic acid) which characterize the EDE as a polyphenol-rich mixture. Using HFF-1 fibroblasts, it was shown that EDE promoted cell regeneration after UVA exposure. It also led to the inhibition of the collagenase, elastase and tyrosinase enzymes, which are involved in skin-related disorders. In terms of toxicological evaluation, the EDE was classified as non-phototoxic through the 3T3 Neutral Red Uptake Phototoxicity Test (OECD N° 432, 2004) and non-eye irritant by Bovine Corneal Opacity and Permeability (OECD N° 437, 2013) assay, in conjunction with corneal histomorphometric analysis. Furthermore, the EDE has no skin sensitization potential as demonstrated by a two-out-of-three prediction model [protein-binding/haptenization (OECD N° 442C, 2015), keratinocyte and dendritic cell activations]. In addition, it was shown that the EDE seems to be non-genotoxic through the cytokinesis-block micronucleus assay (OECD N° 487, 2014) using HepG2 cells. When considered together, these findings support the use of EDE botanical mixture in cosmetic/pharmaceutical products.


Asunto(s)
Cosméticos/química , Cosméticos/toxicidad , Fármacos Dermatológicos/química , Fármacos Dermatológicos/toxicidad , Eugenia/química , Eugenia/toxicidad , Animales , Bovinos , Células Cultivadas , Mezclas Complejas , Seguridad de Productos para el Consumidor , Córnea/efectos de los fármacos , Células Dendríticas/efectos de los fármacos , Dermatitis Fototóxica , Humanos , Interleucina-18/metabolismo , Irritantes/toxicidad , Queratinocitos/efectos de los fármacos , Ratones , Pruebas de Micronúcleos , Extractos Vegetales/química , Extractos Vegetales/toxicidad , Hojas de la Planta/química
8.
J Trop Pediatr ; 63(1): 65-69, 2017 02.
Artículo en Inglés | MEDLINE | ID: mdl-27370817

RESUMEN

Balms and oils containing terpenic compounds, such as camphor, menthol and eucalyptus, are potentially toxic, and numerous reports of adverse events stemming from their use in infants and young children have been published. During qualitative research on newborn practices in rural Cambodia, these products were found to be commonly applied to the skin of newborns and infants and available in most households. Parents and caregivers of infants in Cambodia and other settings where use of camphor- and menthol-containing products are common should be educated on the risks of these to prevent child morbidity and potential mortality.


Asunto(s)
Alcanfor/toxicidad , Terapias Complementarias/estadística & datos numéricos , Fármacos Dermatológicos/toxicidad , Conocimientos, Actitudes y Práctica en Salud , Cuidado del Lactante/métodos , Conducta Materna , Aceites Volátiles/toxicidad , Cambodia , Terapias Complementarias/efectos adversos , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Investigación Cualitativa
9.
Biomed Pharmacother ; 84: 1156-1162, 2016 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27780146

RESUMEN

The aim of present study was to determine the effect of newly formulated gels and suspensions of extractive Phytoconstituents of Woodfordia fructicosa flowers and Gardenia gummifera leaves by using UV Radiation induced psoriasis in rats. Both plants are traditionally claimed to be useful in treatment of number of skin diseases. However, there are no established scientific reports for their potential in psoriasis. Formulated Gels and Suspensions of ethanolic extract of both plants were tested for acute dermal and oral toxicity study respectively. The results of acute dermal toxicity at concentration 1% w/w and oral toxicity at dose 1000mg/kg showed that the gels and suspensions were safe. Psoriasis was induced in Wistar rats by espousing 10% area of total body by UV radiations. Anti-psoriatic activity was performed by applying 0.1% gel and orally at a dose 100mg/kg body weight in rats. Severity Index, histological study and biochemical estimation were analyzed. The results of our studies showed that the test formulations (Gels and Suspensions) of both plant extracts exhibited potential effect in anti-psoriatic activity.


Asunto(s)
Fármacos Dermatológicos/farmacología , Extractos Vegetales/farmacología , Psoriasis/prevención & control , Piel/efectos de los fármacos , Rayos Ultravioleta , Administración Cutánea , Administración Oral , Animales , Fármacos Dermatológicos/aislamiento & purificación , Fármacos Dermatológicos/toxicidad , Modelos Animales de Enfermedad , Etanol/química , Femenino , Gardenia , Geles , Hidroxiprolina/metabolismo , Masculino , Soluciones Farmacéuticas , Fitoterapia , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/toxicidad , Plantas Medicinales , Psoriasis/metabolismo , Psoriasis/patología , Ratas Wistar , Índice de Severidad de la Enfermedad , Piel/metabolismo , Piel/patología , Solventes/química , Woodfordia
10.
Food Chem Toxicol ; 97: 286-296, 2016 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-27658325

RESUMEN

ZnO-np has immense potential and application in cosmetic and health care sectors. Hence it was imperative to assess the toxicity/safety of these nanoparticles. In this study, we have evaluated the effects of ZnO-np in human peripheral blood mononuclear cells (PBMCs) in vitro and in Swiss albino male mice in vivo for cyto-genotoxicity and oxidative damage. In vitro results showed that ZnO-nps were weakly genotoxic, induced significant decrease in mitochondrial membrane potential and was capable of ROS generation, leading to apoptosis. In bone marrow cells in vivo, reduction of mitochondrial membrane potential (MMP), increased oxidative stress and G0/G1 cell cycle arrest was observed along with chromosome aberrations and micronuclei formation. In liver cells DNA damage and induction of oxidative stress with concurrent decrease in inhibition of antioxidant enzymes were noted. These in vitro and in vivo results demonstrated that ZnO-np induced genotoxic response and ROS production leading to apoptotic cell death and established a good co-relation between the two biological systems. More importantly, the results stress on the need of multiple endpoint assay-approaches, with an in vitro-in vivo study design to assess nanoparticle toxicology.


Asunto(s)
Apoptosis/efectos de los fármacos , Médula Ósea/patología , Daño del ADN/efectos de los fármacos , Linfocitos/efectos de los fármacos , Nanopartículas del Metal/administración & dosificación , Estrés Oxidativo/efectos de los fármacos , Óxido de Zinc/toxicidad , Animales , Antioxidantes/metabolismo , Médula Ósea/efectos de los fármacos , Aberraciones Cromosómicas/efectos de los fármacos , Daño del ADN/genética , Fármacos Dermatológicos/administración & dosificación , Fármacos Dermatológicos/toxicidad , Humanos , Técnicas In Vitro , Linfocitos/metabolismo , Masculino , Potencial de la Membrana Mitocondrial/efectos de los fármacos , Ratones , Oxidación-Reducción , Especies Reactivas de Oxígeno/metabolismo , Óxido de Zinc/administración & dosificación
11.
Int J Toxicol ; 35(1 Suppl): 60S-89S, 2016 07.
Artículo en Inglés | MEDLINE | ID: mdl-27383199

RESUMEN

The Cosmetic Ingredient Review (CIR) Expert Panel assessed the safety of 131 alkyl polyethylene glycol (PEG)/polypropylene glycol ethers as used in cosmetics, concluding that these ingredients are safe in the present practices of use and concentration described in this safety assessment when formulated to be nonirritating. Most of the alkyl PEG/PPG ethers included in this review are reported to function in cosmetics as surfactants, skin-conditioning agents, and/or emulsifying agents. The alkyl PEG/PPG ethers share very similar physiochemical properties as the alkyl PEG ethers, which were reviewed previously by the CIR Expert Panel and found safe when formulated to be nonirritating. The alkyl PEG ethers differ by the inclusion of PPG repeat units, which are used to fine-tune the surfactant properties of this group. The Panel relied heavily on data on analogous ingredients, extracted from the alkyl PEG ethers and PPG reports, when making its determination of safety.


Asunto(s)
Seguridad de Productos para el Consumidor , Cosméticos , Éteres/toxicidad , Polietilenglicoles/toxicidad , Glicoles de Propileno/toxicidad , Alquilación , Animales , Fármacos Dermatológicos/química , Fármacos Dermatológicos/farmacocinética , Fármacos Dermatológicos/toxicidad , Emulsionantes/química , Emulsionantes/farmacocinética , Emulsionantes/toxicidad , Éteres/química , Éteres/farmacocinética , Humanos , Polietilenglicoles/química , Polietilenglicoles/farmacocinética , Glicoles de Propileno/química , Glicoles de Propileno/farmacocinética , Tensoactivos/química , Tensoactivos/farmacocinética , Tensoactivos/toxicidad , Pruebas de Toxicidad
12.
Food Chem Toxicol ; 93: 138-44, 2016 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-27185063

RESUMEN

Inhalation of zinc oxide (ZnO) metal fumes is known to cause metal fume fever and to have systemic effects; however, the effects of ZnO nanoparticles (ZnONPs) on the cardiovascular system remain unclear. The objective of this study was to investigate the cardiovascular toxicity of ZnONPs. Human coronary artery endothelial cells (HCAECs) were exposed to ZnONPs of different sizes to investigate the cell viability, 8-hydroxy-2'-deoxyguanosine (8-OHdG), interleukin (IL)-6, nitric oxide (NO), and regulation of cardiovascular disease-related genes. Exposure of HCAECs to ZnONPs resulted in decreased cell viability and increased levels of 8-OHdG, IL-6, and NO. Downregulation of cardiovascular-associated genes was observed in response to ZnONPs in HCAECs determined by qPCR, suggesting that the calcium signaling pathway, neuroactive ligand-receptor interaction, hypertrophic cardiomyopathy, dilated cardiomyopathy, and renin-angiotensin system are important affected pathways in response to ZnONPs. Furthermore, we observed a significant response of AGTR1 to ZnONP exposure in HCAECs. Our results suggest that ZnONPs cause toxicity to HCAECs, which could be associated with cardiovascular dysfunction.


Asunto(s)
Biomarcadores/análisis , Vasos Coronarios/patología , Endotelio Vascular/patología , Nanopartículas del Metal/toxicidad , Receptor de Angiotensina Tipo 1/metabolismo , Óxido de Zinc/toxicidad , Apoptosis/efectos de los fármacos , Calcio/metabolismo , Proliferación Celular/efectos de los fármacos , Células Cultivadas , Vasos Coronarios/efectos de los fármacos , Vasos Coronarios/metabolismo , Fármacos Dermatológicos/toxicidad , Endotelio Vascular/efectos de los fármacos , Endotelio Vascular/metabolismo , Humanos , Interleucina-6/genética , Interleucina-6/metabolismo , Óxido Nítrico/metabolismo , ARN Mensajero/genética , Reacción en Cadena en Tiempo Real de la Polimerasa , Receptor de Angiotensina Tipo 1/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
13.
J Ethnopharmacol ; 175: 470-80, 2015 Dec 04.
Artículo en Inglés | MEDLINE | ID: mdl-26456343

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: Many herbal topical formulations have been marketed worldwide to prevent hair loss or promote hair growth. Certain in vivo studies have shown promising results among them; however, the effectiveness of their bioactive constituents remains unknown. AIM OF THE STUDY: Recently, prostaglandin D2 (PGD2) inhibition has been discovered as a pharmacological mechanism for treating androgenic alopecia (AGA). This present study was aimed to identify prostaglandin D2 synthase (PTGDS) inhibitors in traditional Chinese medicines (TCMs) for treating AGA. MATERIALS AND METHODS: In this study, 389 constituents of 12 selected herbs were docked into 6 different crystal structures of PTGDS. The accuracy of the docking methods was successfully validated with experimental data from the ZINC In Man (Zim) database using receiver operating characteristic (ROC) studies. Seven essential drug properties were predicted for topical formulation: skin permeability, sensitisation, irritation, corrosion, mutagenicity, tumorigenicity and reproductive effects. RESULTS: Many constituents of the twelve herbs were found to have more advanced binding energies than the experimentally proved PTGDS inhibitors, but many of them were indicative of at least one type of skin adverse reactions, and exhibited poor skin permeability. CONCLUSIONS: Overall, ricinoleic acid, acteoside, amentoflavone, quercetin-3-O-rutinoside and hinokiflavone were predicted to be PTGDS inhibitors with good pharmacokinetic properties and minimal adverse skin reactions. These compounds have the highest potential for further in vitro and in vivo investigation with the aim of developing safe and high-efficacy hair loss treatment.


Asunto(s)
Alopecia/tratamiento farmacológico , Inhibidores de la Ciclooxigenasa , Fármacos Dermatológicos , Medicamentos Herbarios Chinos , Oxidorreductasas Intramoleculares/antagonistas & inhibidores , Lipocalinas/antagonistas & inhibidores , Animales , Simulación por Computador , Inhibidores de la Ciclooxigenasa/química , Inhibidores de la Ciclooxigenasa/farmacología , Inhibidores de la Ciclooxigenasa/uso terapéutico , Inhibidores de la Ciclooxigenasa/toxicidad , Fármacos Dermatológicos/química , Fármacos Dermatológicos/farmacología , Fármacos Dermatológicos/uso terapéutico , Fármacos Dermatológicos/toxicidad , Medicamentos Herbarios Chinos/química , Medicamentos Herbarios Chinos/farmacología , Medicamentos Herbarios Chinos/uso terapéutico , Medicamentos Herbarios Chinos/toxicidad , Humanos , Medicina Tradicional China , Modelos Biológicos , Simulación del Acoplamiento Molecular , Relación Estructura-Actividad Cuantitativa , Curva ROC , Piel/efectos de los fármacos , Absorción Cutánea
14.
Toxicol Mech Methods ; 25(4): 334-9, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25980654

RESUMEN

The wide uses of zinc oxide nanoparticles (nano-ZnO) in industrial, cosmetics, medicine, food production and electronics associate with increase in occupational and public exposure. Although, toxicity of nano-ZnO has been extensively studied on many different cell types and animal systems, there is a significant lack of toxicological data focus on nephrotoxic potential of nano-ZnO. In this study, the cyto- and genotoxic effects of nano-ZnO on rat kidney epithelial cells (NRK-52E) were investigated by using different assays. Nano-ZnO (10-50 nm of sizes) were synthesized by sol-gel method. For the cytotoxic effect of nano-ZnO, mean of inhibition concentration (IC50) values in cell line was evaluated by MTT, Trypan Blue (TB) and Neutral Red Uptake (NRU) assays at 25.0-100.0 µg/mL exposure concentrations. Nano-ZnO showed cytotoxic activity by acting on different targets in renal cells, with IC50 ≥ 73.05 µg/mL. Comet assay was used to evaluate the genotoxicity of nano-ZnO (12.5-50.0 µg/mL). Nano-ZnO caused statistically significant DNA damage. Our results highlight the important risk of cyto- and genotoxic effects of nano-ZnO over the kidney.


Asunto(s)
Supervivencia Celular/efectos de los fármacos , Fármacos Dermatológicos/toxicidad , Células Epiteliales/efectos de los fármacos , Riñón/efectos de los fármacos , Nanopartículas del Metal/toxicidad , Mutágenos/toxicidad , Óxido de Zinc/toxicidad , Animales , Línea Celular , Ensayo Cometa , Daño del ADN , Riñón/citología , Estrés Oxidativo/efectos de los fármacos , Tamaño de la Partícula , Ratas
15.
J Obstet Gynaecol Res ; 41(6): 975-8, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25773513

RESUMEN

Isotretinoin is a drug used for treating severe cystic/nodular acne. Severe malformations have been documented in neonates whose mothers had taken isotretinoin during pregnancy. Women who became pregnant one cycle after completing therapy are believed to be at teratogenic risk not higher than baseline. We describe the case of a newborn whose mother had taken the drug for 4 weeks. The woman then had contraception for 4 weeks (after the drug treatment had finished), and became pregnant after that period. The newborn had isolated bilateral microtia due to suspected isotretinoin exposure. His mother also had a history of urine tract infection in the second week of pregnancy that was treated with cephalexin. The parents were not from a consanguineous marriage and had no family history of congenital malformations. To reduce the risk, effective contraception should be continued in fertile women more than 1 month after completing therapy.


Asunto(s)
Anomalías Múltiples/inducido químicamente , Microtia Congénita/inducido químicamente , Fármacos Dermatológicos/toxicidad , Isotretinoína/toxicidad , Intercambio Materno-Fetal , Teratógenos/toxicidad , Puntaje de Apgar , Vermis Cerebeloso/anomalías , Vermis Cerebeloso/efectos de los fármacos , Cesárea , Cisterna Magna/anomalías , Cisterna Magna/efectos de los fármacos , Femenino , Humanos , Recién Nacido , Irán , Masculino , Polihidramnios/inducido químicamente , Polihidramnios/fisiopatología , Polihidramnios/cirugía , Embarazo , Nacimiento a Término
16.
Acta Pol Pharm ; 71(5): 781-8, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25362806

RESUMEN

Naran R is a herbal composition made of Plantago lanceolate folium, Malvae arboreae flos, Calendulae flos, Chamomillae inflorescentia, Lamii albi flos to prepare compresses or to wash skin with inflammations. The extract of this preparation is mixed to be applied as an ointment on patients' skin after radiotherapy. Experiments performed in vitro are part of pre-clinical tests with Naran R ointment. This study examined the impact of the plant composition for ethanol-water extract on human skin fibroblasts (HSF) culture. Samples of extract, prepared from patented amounts of herbs, were in the range of 25-225 µg/mL. Six methods were applied: standard spectrophotometric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, neutral red (NR) uptake assay, DPPH free radical scavenging test, labeling of cytoskeleton F-actin, staining of argyrophilic nucleolar organizer regions (AgNORs) and trypan blue coloration. The extract concentration 75 µg/mL was established as safe for application on human skin. In labeling of F-actin with rhodamine-phalloidin dye at this concentration the cytoskeleton was stable. The extract did not influence the membrane stability and had positive influence on the proliferation activity. It was confirmed in AgNOR test during incubation with extract, which led to formation of larger amount of smaller nucleolins. In DPPH scavenging activity test, the extract revealed over 8% higher free-radical scavenging activity in comparison to control. After trypan blue staining, the extract in concentration 125 µg/mL significantly lowered the cell viability. When the cytotoxic and anti-proliferative activity of the extracts were analyzed, MTT and Neutral Red (NR) methods were used. The cells' viability was maintained on a constant level (80-110%) after 24, 48 and 72 h of incubation. During all time of NR test (72 h) and even when 225 µg/mL of extract was applied, the viability of cells was in range 80-110% of control. Positive influence of the extract on investigated cells structure and proliferation, lack of toxicity and increasing anti-oxidant activity enable to consider this preparation as a natural remedy with potential application in skin therapy after radiation.


Asunto(s)
Antioxidantes/farmacología , Fármacos Dermatológicos/farmacología , Extractos Vegetales/farmacología , Radiodermatitis/tratamiento farmacológico , Piel/efectos de los fármacos , Administración Cutánea , Antioxidantes/administración & dosificación , Antioxidantes/química , Antioxidantes/toxicidad , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Fármacos Dermatológicos/administración & dosificación , Fármacos Dermatológicos/química , Fármacos Dermatológicos/toxicidad , Etanol/química , Humanos , Masculino , Pomadas , Fitoterapia , Extractos Vegetales/administración & dosificación , Extractos Vegetales/química , Extractos Vegetales/toxicidad , Plantas Medicinales , Radiodermatitis/etiología , Radiodermatitis/patología , Piel/patología , Piel/efectos de la radiación , Agua/química
17.
Anal Bioanal Chem ; 406(21): 5203-12, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-24924210

RESUMEN

A highly sensitive method for the determination of sulfur mustard (SM) metabolites thiodiglycol (TDG) and thiodiglycol sulfoxide (TDGO) in urine was established and validated using isotope-dilution negative-ion chemical ionization (NICI) gas chromatography-mass spectrometry (GC-MS). TDGO in the samples was reduced with TiCl3, and then determined together with TDG as a single analyte. The sample preparation procedures, including two solid-phase-extraction (SPE) clean-up steps, were optimized to improve the sensitivity of the method. The limits of detection (LOD) for both TDG and TDG plus TDGO (TDG + TDGO) were 0.1 ng mL(-1), and the limits of quantitation (LOQ) for both were 0.3 ng mL(-1). The method was used in a rabbit cutaneous SM exposure model. Domestic rabbits were exposed to neat liquid SM at three dosage levels (0.02, 0.05, and 0.15 LD50), and the urinary excretion of four species of hydrolysis metabolites, namely free TDG, free plus conjugated TDG (total TDG), free TDG + TDGO, and free plus conjugated TDG + TDGO (total TDG + TDGO), was evaluated to investigate the metabolic processes. The total urinary excretion profiles of the metabolites, including the peak time, time window, and dose-response and time-response relationships, were clarified. The results revealed that the concentrations of TDG and TDG + TDGO in the urine increased quickly and then decreased rapidly in the first two days after SM exposure. The cumulative amount of total TDG + TDGO excreted in urine during the first five days accounted for 0.5-1% of the applied dose of SM. It is also concluded that TDG and TDGO in urine existed mainly in free form, the levels of glucuronide and of sulfate conjugates of TDG or TDGO were very low, and most hydrolysis metabolites were present in the oxidized form (TDGO). The study indicates that the abnormal increase of TDG and TDGO excretion levels can be used as a diagnostic indicator and establishes a reference time-window for retrospective analysis and sampling after SM exposure.


Asunto(s)
Sustancias para la Guerra Química/toxicidad , Fármacos Dermatológicos/toxicidad , Gas Mostaza/toxicidad , Compuestos de Sulfhidrilo/orina , Sulfóxidos/orina , Administración Cutánea , Animales , Biotransformación , Sustancias para la Guerra Química/metabolismo , Fármacos Dermatológicos/metabolismo , Relación Dosis-Respuesta a Droga , Cromatografía de Gases y Espectrometría de Masas/métodos , Técnicas de Dilución del Indicador , Masculino , Gas Mostaza/metabolismo , Oxidación-Reducción , Conejos , Piel/irrigación sanguínea , Piel/efectos de los fármacos , Piel/metabolismo , Extracción en Fase Sólida , Titanio/química
18.
Toxicol In Vitro ; 27(7): 2067-75, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23851002

RESUMEN

Uncontrolled inflammation contributes to cutaneous damage following exposure to the warfare agent bis(2-chloroethyl) sulfide (sulfur mustard, SM). Activation of the p38 mitogen activated protein kinase (MAPK) precedes SM-induced cytokine secretion in normal human epidermal keratinocytes (NHEKs). This study examined the role of p38-regulated MAPK activated kinase 2 (MK2) during this process. Time course analysis studies using NHEK cells exposed to 200µM SM demonstrated rapid MK2 activation via phosphorylation that occurred within 15 min. p38 activation was necessary for MK2 phosphorylation as determined by studies using the p38 inhibitor SB203580. To compare the role of p38 and MK2 during SM-induced cytokine secretion, small interfering RNA (siRNA) targeting these proteins was utilized. TNF-α, IL-1ß, IL-6 and IL-8 secretion was evaluated 24h postexposure, while mRNA changes were quantified after 8h. TNF-α, IL-6 and IL-8 up regulation at the protein and mRNA level was observed following SM exposure. IL-1ß secretion was also elevated despite unchanged mRNA levels. p38 knockdown reduced SM-induced secretion of all the cytokines examined, whereas significant reduction in SM-induced cytokine secretion was only observed with TNF-α and IL-6 following MK2 knockdown. Our observations demonstrate potential activation of other p38 targets in addition to MK2 during SM-induced cytokine secretion.


Asunto(s)
Sustancias para la Guerra Química/toxicidad , Citocinas/metabolismo , Fármacos Dermatológicos/toxicidad , Péptidos y Proteínas de Señalización Intracelular/agonistas , Queratinocitos/efectos de los fármacos , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Gas Mostaza/toxicidad , Antiinflamatorios no Esteroideos/farmacología , Células Cultivadas , Sustancias para la Guerra Química/química , Citocinas/química , Citocinas/genética , Fármacos Dermatológicos/antagonistas & inhibidores , Humanos , Péptidos y Proteínas de Señalización Intracelular/antagonistas & inhibidores , Péptidos y Proteínas de Señalización Intracelular/genética , Péptidos y Proteínas de Señalización Intracelular/metabolismo , Irritantes/antagonistas & inhibidores , Irritantes/toxicidad , Queratinocitos/citología , Queratinocitos/inmunología , Queratinocitos/metabolismo , Cinética , Gas Mostaza/química , Fosforilación/efectos de los fármacos , Inhibidores de Proteínas Quinasas/farmacología , Procesamiento Proteico-Postraduccional/efectos de los fármacos , Proteínas Serina-Treonina Quinasas/antagonistas & inhibidores , Proteínas Serina-Treonina Quinasas/genética , Proteínas Serina-Treonina Quinasas/metabolismo , Interferencia de ARN , ARN Mensajero/metabolismo , ARN Interferente Pequeño , Regulación hacia Arriba/efectos de los fármacos , Proteínas Quinasas p38 Activadas por Mitógenos/antagonistas & inhibidores , Proteínas Quinasas p38 Activadas por Mitógenos/química , Proteínas Quinasas p38 Activadas por Mitógenos/genética , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo
19.
Toxicol In Vitro ; 27(2): 900-7, 2013 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-23318729

RESUMEN

Isotretinoin is a retinoic acid frequently used in monotherapy or combined with narrow-band ultraviolet B (NBUVB) irradiation to treat patients with acne and psoriasis vulgaris. As both diseases need frequent and/or prolonged therapeutic interventions, the study of the genotoxicity of retinoids becomes important. Our aim was to study the genotoxic effects of isotretinoin alone or combined with NBUVB. In vitro studies were performed in the absence of S9 metabolic activation using blood from five healthy volunteers, incubated 72 h with isotretinoin (1.2-20 µM) (i.e., at concentrations usually achieved in blood with therapeutic doses as well as at higher concentrations). In vivo studies were also performed using blood from two patients with acne and three patients with psoriasis vulgaris treated with isotretinoin in monotherapy (8 or 20mg/day) or combined with NBUVB (20mg isotretinoin/day+NBUVB). The genotoxic effect was evaluated by the cytokinesis-blocked micronucleus and the comet assays. Our studies showed that isotretinoin alone was not genotoxic when tested in human lymphocytes in vitro and in vivo. There was no clear genotoxic effect in psoriatic patients treated with isotretinoin and NBUVB. The in vitro studies showed that isotretinoin induced apoptosis and necrosis in human lymphocytes at higher doses.


Asunto(s)
Acné Vulgar/tratamiento farmacológico , Fármacos Dermatológicos/toxicidad , Isotretinoína/toxicidad , Linfocitos/efectos de los fármacos , Psoriasis/tratamiento farmacológico , Acné Vulgar/radioterapia , Adulto , Apoptosis/efectos de los fármacos , Células Cultivadas , Terapia Combinada , Ensayo Cometa , Citocinesis , Femenino , Humanos , Linfocitos/metabolismo , Masculino , Pruebas de Micronúcleos , Necrosis/inducido químicamente , Psoriasis/radioterapia , Rayos Ultravioleta
20.
Int J Toxicol ; 31(5 Suppl): 245S-60S, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23064775

RESUMEN

Propylene glycol is an aliphatic alcohol that functions as a skin conditioning agent, viscosity decreasing agent, solvent, and fragrance ingredient in cosmetics. Tripropylene glycol functions as a humectant, antioxidant, and emulsion stabilizer. Polypropylene glycols (PPGs), including PPG-3, PPG-7, PPG-9, PPG-12, PPG-13, PPG-15, PPG-16, PPG-17, PPG-20, PPG-26, PPG-30, PPG-33, PPG-34, PPG-51, PPG-52, and PPG-69, function primarily as skin conditioning agents, with some solvent use. The majority of the safety and toxicity information presented is for propylene glycol (PG). Propylene glycol is generally nontoxic and is noncarcinogenic. Clinical studies demonstrated an absence of dermal sensitization at use concentrations, although concerns about irritation remained. The CIR Expert Panel determined that the available information support the safety of tripropylene glycol as well as all the PPGs. The Expert Panel concluded that PG, tripropylene glycol, and PPGs ≥3 are safe as used in cosmetic formulations when formulated to be nonirritating.


Asunto(s)
Seguridad de Productos para el Consumidor , Cosméticos/química , Fármacos Dermatológicos/toxicidad , Polímeros/toxicidad , Propilenglicol/toxicidad , Glicoles de Propileno/toxicidad , Administración Cutánea , Animales , Antioxidantes/administración & dosificación , Antioxidantes/química , Antioxidantes/farmacocinética , Antioxidantes/toxicidad , Cosméticos/toxicidad , Fármacos Dermatológicos/administración & dosificación , Fármacos Dermatológicos/química , Fármacos Dermatológicos/farmacocinética , Humanos , Polímeros/administración & dosificación , Polímeros/química , Polímeros/farmacocinética , Propilenglicol/administración & dosificación , Propilenglicol/química , Propilenglicol/farmacocinética , Glicoles de Propileno/administración & dosificación , Glicoles de Propileno/química , Glicoles de Propileno/farmacocinética , Cuidados de la Piel/efectos adversos , Pruebas de Toxicidad , Viscosidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA